RUNX1 and acute myeloid leukemia: To determine whether MLT has potential anti‐leukaemia activity in leukemic cells bearing AML1‐ETO, apoptosis, proliferation and colony formation were analysed in MLT‐treated leukemic cell lines and primary AML blasts.